Highest versus lowest serum concentrations were associated with superior survival.
Controversy has swirled around the relationship between serum vitamin D levels and both the risk for developing breast cancer and the prognosis for those who develop breast cancer. Results from various reports exploring these potential associations have been criticized for issues with methodology and conflicting results.
Now, investigators have conducted a prospective, case–cohort analysis of the Pathways Study (Cancer Causes Control 2008; 19:1065), involving 4505 women (median age, 58.7) in the Kaiser Permanente Northern California health plan who had an incident diagnosis of breast cancer and were followed for outcomes and comorbidities at baseline, 12, 24, 48, 72, and 96 months. Most patients had estrogen-receptor–positive, stage I–III di…
Reviewing Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)